Inhibitory effect of bortezomib on human multiple myeloma cells when combined with epigallocatechin-gallate (EGCG) analogs

MedChemComm

Volumn 3, Issue 2, 2012, Pages 229-232

  Pamu, Sreedhar ^a   Chen, Di ^b   Morin, Fred ^a   Huo, Congde ^a,c   Cui, Qiuzhi ^b   Dou, Q Ping ^b   Chan, Tak Hang ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 BENZENEDIOL; BENZENE DERIVATIVE; BORTEZOMIB; EPIGALLOCATECHIN GALLATE; EPIGALLOCATECHIN GALLATE DERIVATIVE; RESORCINOL; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 84863131160     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c1md00260k     Document Type: Article

References (19)

1. J. Adams M. Behnke S. Chen A. A. Cruickshank L. R. Dick L. Grenier J. M. Klunder Y.-T. Ma L. Plamondon R. L. Stein Bioorg. Med. Chem. Lett. 1998 8 333 338
2. R. C. Kane P. F. Bross A. T. Farrell R. Pazdur Oncologist 2003 8 508 513
3. H. Ludwig D. Khayat G. Giaccone T. Facon Cancer 2005 104 1794 1807
4. P. G. Richardson P. Sonneveld M. W. Schuster D. Irwin E. A. Stadtmauer T. Facon J.-L. Harousseau D. Ben-Yehuda S. Lonial J.-F. San Miguel J. D. Cavenagh K. C. Anderson Br. J. Haematol. 2007 137 429 435
5. S. Markovina N. S. Callander S. L. O'Connor J. Kim J. E. Werndl M. Raschko C. P. Leith B. S. Kahl K. M. Kim S. Miyamoto Mol. Cancer Res. 2008 6 1356 1364
6. G. Perrone T. Hideshima H. Ikeda Y. Okawa E. Calabrese G. Gorgun L. Santo D. Cirstea N. Raje D. Chauhan M. Baccarani M. Cavo K. C. Anderson Leukemia 2009 23 1679 1686
7. F. T. Liu G. Samir Z. M. Agrawal Z. Movasaghi P. B. Wyatt I. U. Rehman J. G. Gribben A. C. Newland L. Jia Blood 2008 112 3835 3846
8. E. B. Golden P. Y. Lam A. Kardosh K. J. Gaffney E. Cadenas S. G. Louie N. A. Petasis T. C. Chen A. H. Schönthal Blood 2009 113 5927 5937
9. T. Y. Kim J. Park B. Oh H. J. Min T.-S. Jeong J. H. Lee C. Suh J.-W. Cheong H. J. Kim S.-S. Yoon S. B. Park D. S. Lee The Korean Multiple Myeloma Working Party Br. J. Haematol. 2009 146 270 281
10. Y. Hara, Green Tea, Health Benefits and Applications, Marcel Dekker, New York, 2001
11. D. Chen K. G. Daniel D. J. Kuhn A. Kazi M. Bhuiyan L. Li Z. Wang S. B. Wan W. H. Lam T. H. Chan Q. P. Dou Front. Biosci. Sept 1 2004 9 2618 2631
12. S. Nam D. M. Smith P. Q. Dou J. Biol. Chem. 2001 276 13322 13330
13. D. M. Smith K. G. Daniel Z. Wang W. C. Guida T. H. Chan Q. P. Dou Proteins: Struct., Funct., Bioinf. 2004 54 58 70
14. C. Huo H. Yang Q. C. Cui Q. P. Dou T. H. Chan Bioorg. Med. Chem. 2010 18 1252 1258
15. A. H. Wu C. C. Tseng D. Van Den Berg M. C. Yu Canc. Res. 2003 63 7526 7529
16. K. R. Landis-Piwowar S. B. Wan R. A. Wiegand D. J. Kuln T. H. Chan Q. P. Dou J. Cell. Physiol. 2007 213 252 260
17. P. Kebarle U. H. Verkerk Mass Spectrom. Rev. 2009 28 898 917
18. M. B. Smith and J. March, March's Advanced Organic Chemistry, Reactions, Mechanisms and Structure, John Wiley and Sons, New York, 6th edn, 2007, p. 226
19. K. R. Landis-Piwowar C. Huo D. Chen V. Milacic G. Shi T. H. Chan Q. P. Dou Canc. Res. 2007 67 4303 4310